Psychemedics Corporation (PMD) Announces Earnings Results
Psychemedics Corporation (NASDAQ:PMD) released its earnings results on Tuesday. The company reported $0.25 EPS for the quarter, Bloomberg Earnings reports. Psychemedics Corporation had a net margin of 17.59% and a return on equity of 47.94%.
Shares of Psychemedics Corporation (NASDAQ PMD) traded down 0.12% during mid-day trading on Tuesday, reaching $16.63. 13,156 shares of the company’s stock traded hands. The firm’s 50-day moving average is $18.30 and its 200 day moving average is $21.10. The firm has a market cap of $91.32 million, a price-to-earnings ratio of 12.27 and a beta of 1.00. Psychemedics Corporation has a one year low of $13.81 and a one year high of $27.99.
In other news, VP Michael I. Schaffer sold 4,400 shares of the firm’s stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $20.37, for a total transaction of $89,628.00. Following the transaction, the vice president now directly owns 41,273 shares in the company, valued at $840,731.01. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, VP Michael I. Schaffer sold 7,548 shares of the firm’s stock in a transaction that occurred on Wednesday, September 6th. The stock was sold at an average price of $20.41, for a total transaction of $154,054.68. Following the transaction, the vice president now owns 41,273 shares in the company, valued at $842,381.93. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 12,929 shares of company stock worth $264,441. Insiders own 8.60% of the company’s stock.
About Psychemedics Corporation
Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment.
Receive News & Ratings for Psychemedics Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Psychemedics Corporation and related companies with MarketBeat.com's FREE daily email newsletter.